Research ArticleCardiovascular

PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice

Rui Wang, Lei Xi and Rakesh C. Kukreja
Journal of Pharmacology and Experimental Therapeutics April 2017, 361 (1) 29-38; DOI: https://doi.org/10.1124/jpet.116.239087
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
Publication Date - String

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleCardiovascular

Tadalafil and Hydroxychloroquine Protect Diabetic Heart

Rui Wang, Lei Xi and Rakesh C. Kukreja
Journal of Pharmacology and Experimental Therapeutics April 1, 2017, 361 (1) 29-38; DOI: https://doi.org/10.1124/jpet.116.239087
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section